02 October 2018
As a part of CPhl Worldwide 2018, a collective exposition of Russian pharmaceutical companies will be displayed. The Russian pavilion (stand ¹ 12F40) is operated by S.GROUP Corporate Communications LLC.
On 9 to 11 October. 2018, Madrid (Spain) will be hosting CPhl Worldwide 2018, the 29th global pharmaceutical exhibition and the world's leading event In the Industry.
Exhibiting under the auspices of the Ministry of Industry and Trade of the Russian Federation, Russia will be represented by thirteen pharmaceutical companies, including both well-known players of the domestic and global pharmaceutical markets and those who have started conquering these markets relatively recently. The joint exposition of pharmaceutical manufacturers is one of the effective measures to promote non-commodity exports.
…
NovaMedica Innotech is a first-timer at Cphl WorldWide. This is the first opportunity for the company to introduce its products to the European market. NovaMedica Innotech Technology Centre opened its doors in April 2017 in Moscow. It possesses a unique range of innovative Technology platforms for the development and pilot productions of advanced, completive and effective pharmaceuticals.
At present, the company has around 20 research projects in progress, including those under contacts with Russian and foreign partners. One of the targets on the roadmap is to expand the scope of its international cooperation. Besides, NovaMedica Innotech offers its manufacturing facilities for the localization of high-tech dosage forms in Russia, which may be of interest to global companies applying for public procurement programmer.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
The overall mortality rate of the population in Russia decreased by 7% in 2023
28 March 2024
Russia to collaborate with Hungary and Serbia in nuclear medicine
28 March 2024
Researchers propose novel test for pyrogen detection
27 March 2024
Parkinson’s infusion treatment demonstrates advantage over oral delivery
27 March 2024